Literature DB >> 28492534

Response to de Vries et al.

Mrudu Herbert1, Zoheb B Kazi1, Susan Richards2, Amy S Rosenberg3, Priya S Kishnani1.   

Abstract

Entities:  

Year:  2017        PMID： 28492534     DOI： 10.1038/gim.2017.48

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  4 in total

1.  Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.

Authors:  P S Kishnani; D Corzo; M Nicolino; B Byrne; H Mandel; W L Hwu; N Leslie; J Levine; C Spencer; M McDonald; J Li; J Dumontier; M Halberthal; Y H Chien; R Hopkin; S Vijayaraghavan; D Gruskin; D Bartholomew; A van der Ploeg; J P Clancy; R Parini; G Morin; M Beck; G S De la Gastine; M Jokic; B Thurberg; S Richards; D Bali; M Davison; M A Worden; Y T Chen; J E Wraith
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

2.  The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease.

Authors:  Suhrad G Banugaria; Sean N Prater; Yiu-Ki Ng; Joyce A Kobori; Richard S Finkel; Roger L Ladda; Yuan-Tsong Chen; Amy S Rosenberg; Priya S Kishnani
Journal:  Genet Med       Date:  2011-08       Impact factor: 8.822

3.  CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy.

Authors:  Kathryn L Berrier; Zoheb B Kazi; Sean N Prater; Deeksha S Bali; Jennifer Goldstein; Mihaela C Stefanescu; Catherine W Rehder; Eleanor G Botha; Carolyn Ellaway; Kaustuv Bhattacharya; Anna Tylki-Szymanska; Nesrin Karabul; Amy S Rosenberg; Priya S Kishnani
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

4.  Pompe disease in adulthood: effects of antibody formation on enzyme replacement therapy.

Authors:  Juna M de Vries; Esther Kuperus; Marianne Hoogeveen-Westerveld; Marian A Kroos; Stephan C A Wens; Merel Stok; Nadine A M E van der Beek; Michelle E Kruijshaar; Dimitris Rizopoulos; Pieter A van Doorn; Ans T van der Ploeg; W W M Pim Pijnappel
Journal:  Genet Med       Date:  2016-06-30       Impact factor: 8.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.